Bluejay Diagnostics (BJDX) Research & Development (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Research & Development of $811837.0 for Q1 2026, up 38.5% sequentially from $586144.0 in Q4 2025, and up 3.45% YoY from $784800.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Research & Development (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Research & Development for 7 years, with the latest figure at $811837.0 in Q1 2026.
- Quarterly Research & Development rose 3.45% year-over-year to $811837.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 5.15% YoY) and the FY2025 annual result came in at $3.0 million, down 12.25% from the prior year.
- Research & Development rose to $811837.0 in Q1 2026 per BJDX's latest filing, from $586144.0 in the prior quarter.
- Over five years, Research & Development peaked at $1.7 million in Q2 2023 and troughed at $53685.0 in Q1 2022.
- A 5-year average of $973933.1 and a median of $889896.0 in 2025 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2024: Research & Development jumped 2423.14% in 2023, then tumbled 60.52% in 2024.
- Over 5 years, Research & Development stood at $1.3 million in 2022, then decreased by 2.65% to $1.3 million in 2023, then sank by 56.94% to $553997.0 in 2024, then increased by 5.8% to $586144.0 in 2025, then jumped by 38.5% to $811837.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $811837.0, $586144.0, and $785608.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Bluejay Diagnostics | 1.92 Mn | 1.92 Mn | - | 1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Mn |
| Mar 31, 2026 | 811,837.00 |
| Dec 31, 2025 | 586,144.00 |
| Sep 30, 2025 | 785,608.00 |
| Jun 30, 2025 | 889,896.00 |
| Mar 31, 2025 | 784,800.00 |
| Dec 31, 2024 | 553,997.00 |
| Sep 30, 2024 | 551,655.00 |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 756,283.00 |
| Mar 31, 2022 | 53,685.00 |
| Dec 31, 2021 | -402,976.00 |
| Sep 30, 2021 | 442,527.00 |